| Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system). | |
| | |
MedLine Citation:
|
PMID: 21722597 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Food and Drug Administration in collaboration with the National Institutes of Health presented a public workshop to facilitate medical device innovation in the development of the artificial pancreas (or autonomous system) for the treatment of diabetes mellitus on November 10, 2010 in Gaithersburg, Maryland. The purpose of the workshop was to discuss four aspects of artificial pancreas research and development, including: (1) the current state of device systems for autonomous systems for the treatment of diabetes mellitus; (2) challenges in developing this expert device system using existing technology; (3) clinical expectations for these systems; and (4) development plans for the transition of this device system toward an outpatient setting. The patients discussed how clinical science, system components, and regulatory policies will all need to harmonize in order to achieve the goal of seeing an AP product brought forward to the marketplace for patients to use. |
| | |
Authors:
|
David C Klonoff; Charles L Zimliki; Lcdr Alan Stevens; Patricia Beaston; Arleen Pinkos; Sally Y Choe; Guillermo Arreaza-Rubín; William Heetderks |
Related Documents
:
|
8123897 - Orocaecal transit, bacterial overgrowth and hydrogen production in diabetes mellitus. 7386737 - Vasoactive intestinal peptide-associated inhibition of stimulated gastric secretion. ii... 22378557 - Early diagnosis of invasive pulmonary aspergillosis in a young immunocompetent patient. 10903007 - Review article: gall-bladder motor function in diabetes mellitus. 15787347 - Characteristics of end stage renal disease diabetic patients in two countries with diff... 10641177 - Effect of betacarotene on protein glycosylation in alloxan induced diabetic rats. |
Publication Detail:
|
Type: Congresses Date: 2011-05-01 |
Journal Detail:
|
Title: Journal of diabetes science and technology Volume: 5 ISSN: 1932-2968 ISO Abbreviation: J Diabetes Sci Technol Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-07-04 Completed Date: 2012-03-25 Revised Date: 2012-05-01 |
Medline Journal Info:
|
Nlm Unique ID: 101306166 Medline TA: J Diabetes Sci Technol Country: United States |
Other Details:
|
Languages: eng Pagination: 804-26 Citation Subset: IM |
Copyright Information:
|
© 2011 Diabetes Technology Society. |
Affiliation:
|
Mills-Peninsula Health Services, San Mateo, California, USA. dklonoff@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Algorithms Animals Blood Glucose / analysis Diabetes Mellitus / therapy* Diffusion of Innovation Equipment Design Expert Systems Humans Maryland National Institutes of Health (U.S.) Outpatients Pancreas, Artificial* United States United States Food and Drug Administration |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Self-management support interventions that are clinically linked and technology enabled: can they su...
Next Document: De novo once-monthly darbepoetin alpha treatment for the anemia of chronic kidney disease using a co...